Wegovy-maker Novo Nordisk extends curb on provide of weight-loss drug, raises outlook
A collection of injector pens for the Saxenda weight reduction drug are proven on this picture illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk, which makes blockbuster drug Wegovy, raised its outlook for 2023 Thursday however stated it’s extending provide restrictions for some doses of the weight-loss drug. The Danish pharmaceutical firm … Read more